Clinical Trial Update: Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor Detection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating peginterferon alfa-2b for HBeAg-positive chronic hepatitis B, examining the impact of interferon gene mutations and receptor d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Peginterferon alfa-2b (Peginterferon alfa-2b)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Chronic Hepatitis b | Phase 4 | Status: UNKNOWN